31 Aug NuVasive to Participate in Investor Events in September 2020

Posted at 00:00h in News by
0 Likes

SAN DIEGO, Aug. 31, 2020 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following virtual investor events in September:

  • Wells Fargo Securities 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 10:00 a.m. ET / 7:00 a.m. PT;
  • Baird 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 9:40 a.m. ET / 6:40 a.m. PT; and
  • Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Monday, September 14, 2020 at 12:00 p.m. ET / 9:00 a.m. PT.

A live webcast of the presentations will be available online from the Investor Relations page of the Company’s website at www.nuvasive.com. A replay of the presentations will remain available on the website for 30 days after the live webcast.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company’s less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company’s comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,800 employees and operates in more than 50 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA® platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

SOURCE NuVasive, Inc.  / PRNewswire August 2020

Related Links
http://www.nuvasive.com